| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4abc1220f04941ffe56f269ae53401e4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0276
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-3401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-1003 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-0208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-0247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M39-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06 |
| filingDate |
2016-07-14^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-09-24^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74404a20d78265e566da8d8562c57f92 |
| publicationDate |
2019-09-24^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10420923-B1 |
| titleOfInvention |
Method and device for intrathecal administering of immunoglobulin |
| abstract |
A device for providing an implanted injection site capable of delivering a therapeutic substance or medication into the subarachnoid space. The receiving compartment is implanted under the skin adjacent the spine. Injections may be made repeatedly into the membrane for delivering the therapeutic substance without the need for repeated spinal taps. Medications such as immunoglobulin may be administered intrathecally directly into the central nervous system bypassing the blood brain barrier providing more concentrated, effective and less costly treatment of diseases such as Alzheimer's disease. Another embodiment is a method of administering an immunoglobulin composition having a four to six percent concentration incrementally over time by alternately removing cerebrospinal fluid and injecting the immunoglobulin composition. |
| priorityDate |
2010-08-10^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |